HuagongsheHuagongshe Chemistry Print Report · For research reference only
Ethyl chloroformate → Ethyl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Ethyl chloroformate | HCID 10928 | — |
| Reactant | Solifenacin | HCID 154059 | — |
| Reactant | (1S)-1,2,3,4-Tetrahydro-1-phenylisoquinoline | HCID 1382087 | — |
| Product | Ethyl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate | HCID 25178885 | — |
Reaction Steps
According to the process disclosed in U.S. Pat. No. 6,017,927, Solifenacin may be prepared by condensation of (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline of formula (III) with ethyl chloroformate to produce (1S)-ethyl 1-phenyl-1,2,3,4-tetrahydro-2-isoquinolinecarboxylate of formula (IV), which is further reacted with (R)-(−)-3-quinuclidinol of formula (V) to produce Solifenacin (II). Solifenacin is converted to Solifenacin hydrochloride by treating with HCl.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08772491B2 |
| Source dataset | uspto-grants-2014_07 |
| ORD ID | ord-00c38d5e7d7b472cbc1825d2569ff17b |
| Source note | uspto-grants-2014_07 |